FGFR4 and neoplasm: This led to the discovery of 36 putative tumor-surface antigens, such as integrin beta-6 (ITGB6), fibroblast growth factor receptor-4 (FGFR4), and ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) [100].